177 related articles for article (PubMed ID: 35359182)
21. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
22. Surgical and molecular pathology of pancreatic neoplasms.
Hackeng WM; Hruban RH; Offerhaus GJ; Brosens LA
Diagn Pathol; 2016 Jun; 11(1):47. PubMed ID: 27267993
[TBL] [Abstract][Full Text] [Related]
23. Large solid-pseudopapillary neoplasm of the pancreas with aberrant protein expression and mutation of β-catenin: a case report and literature review of the distribution of β-catenin mutation.
Kobayashi T; Ozasa M; Miyashita K; Saga A; Miwa K; Saito M; Morioka M; Takeuchi M; Takenouchi N; Yabiku T; Kanno H; Yuzawa S; Tanino M; Tanaka S; Kawakami H; Asaka M; Sakamoto N
Intern Med; 2013; 52(18):2051-6. PubMed ID: 24042511
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation.
Uemura S; Matsubayashi H; Kiyozumi Y; Uesaka K; Yamamoto Y; Sasaki K; Abe M; Urakami K; Kusuhara M; Yamaguchi K
Fam Cancer; 2018 Apr; 17(2):255-259. PubMed ID: 28755079
[TBL] [Abstract][Full Text] [Related]
25. Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.
Topham JT; Karasinska JM; Lee MKC; Csizmok V; Williamson LM; Jang GH; Denroche RE; Tsang ES; Kalloger SE; Wong HL; O'Kane GM; Moore RA; Mungall AJ; Notta F; Loree JM; Wilson JM; Bathe O; Tang PA; Goodwin R; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
Clin Cancer Res; 2021 Jan; 27(1):150-157. PubMed ID: 33051307
[TBL] [Abstract][Full Text] [Related]
26. Sclerosing epithelioid mesenchymal neoplasm of the pancreas - a proposed new entity.
Basturk O; Weigelt B; Adsay V; Benhamida JK; Askan G; Wang L; Arcila ME; Zamboni G; Fukushima N; Gularte-Mérida R; Da Cruz Paula A; Selenica P; Kumar R; Pareja F; Maher CA; Scholes J; Oda Y; Santini D; Doyle LA; Petersen I; Flucke U; Koelsche C; Reynolds SJ; Yavas A; Deimling AV; Reis-Filho JS; Klimstra DS
Mod Pathol; 2020 Mar; 33(3):456-467. PubMed ID: 31383964
[TBL] [Abstract][Full Text] [Related]
27. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.
Sugimori M; Sugimori K; Tsuchiya H; Suzuki Y; Tsuyuki S; Kaneta Y; Hirotani A; Sanga K; Tozuka Y; Komiyama S; Sato T; Tezuka S; Goda Y; Irie K; Miwa H; Miura Y; Ishii T; Kaneko T; Nagahama M; Shibata W; Nozaki A; Maeda S
Cancer Sci; 2020 Jan; 111(1):266-278. PubMed ID: 31746520
[TBL] [Abstract][Full Text] [Related]
28. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
29. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
Min Kim S; Sun CD; Park KC; Kim HG; Lee WJ; Choi SH
J Surg Oncol; 2006 Oct; 94(5):418-25. PubMed ID: 16967453
[TBL] [Abstract][Full Text] [Related]
31. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
32. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.
Starzyńska T; Karczmarski J; Paziewska A; Kulecka M; Kuśnierz K; Żeber-Lubecka N; Ambrożkiewicz F; Mikula M; Kos-Kudła B; Ostrowski J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586046
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the clinicopathological features of pancreatic solid pseudopapillary neoplasms between males and females: gender does matter.
Zou Y; Huang Y; Hong B; Xiang X; Zhou B; Wei S
Histol Histopathol; 2020 Mar; 35(3):257-268. PubMed ID: 31478554
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic analogue solid pseudopapillary neoplasm arising in the paratesticular location. The first case report.
Michal M; Bulimbasic S; Coric M; Sedivcova M; Kazakov DV; Michal M; Hes O
Hum Pathol; 2016 Oct; 56():52-6. PubMed ID: 27342913
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma.
Luchini C; Pea A; Lionheart G; Mafficini A; Nottegar A; Veronese N; Chianchiano P; Brosens LA; Noë M; Offerhaus GJA; Yonescu R; Ning Y; Malleo G; Riva G; Piccoli P; Cataldo I; Capelli P; Zamboni G; Scarpa A; Wood LD
J Pathol; 2017 Oct; 243(2):148-154. PubMed ID: 28722124
[TBL] [Abstract][Full Text] [Related]
36. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
[TBL] [Abstract][Full Text] [Related]
37. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma.
Vanoli A; Argenti F; Vinci A; La Rosa S; Viglio A; Riboni R; Necchi V; Pugliese L; Sessa F; Pietrabissa A; Paulli M
Virchows Arch; 2015 Aug; 467(2):237-45. PubMed ID: 25989715
[TBL] [Abstract][Full Text] [Related]
38. A case of clear cell variant of solid-pseudopapillary tumor of the pancreas in an adult male patient.
Tanino M; Kohsaka S; Kimura T; Tabu K; Nishihara H; Sawa H; Kawami H; Kamada H; Shimizu M; Tanaka S
Ann Diagn Pathol; 2012 Apr; 16(2):134-40. PubMed ID: 21396870
[TBL] [Abstract][Full Text] [Related]
39. Concentrations of trace elements and KRAS mutations in pancreatic ductal adenocarcinoma.
Gómez-Tomás Á; Pumarega J; Alguacil J; Amaral AFS; Malats N; Pallarès N; Gasull M; Porta M;
Environ Mol Mutagen; 2019 Oct; 60(8):693-703. PubMed ID: 31066938
[TBL] [Abstract][Full Text] [Related]
40. Nonductal Pancreatic Cancers.
Jun SY; Hong SM
Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
